The European medicines regulator says that “unusual blood clots” should be listed as a “very rare” side-effect of the Oxford-AstraZeneca COVID vaccine.
The European medicines regulator says that “unusual blood clots” should be listed as a “very rare” side-effect of the Oxford-AstraZeneca COVID vaccine.